Cancer clot clues: scientists hunt why tumors raise blood clot risk

NCT ID NCT06672250

Recruiting now Knowledge-focused Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at why cancer patients have a much higher risk of developing blood clots. Researchers will collect blood clots from 120 patients (with and without cancer) who undergo a procedure to remove clots. They will analyze the clots for cancer cells and other factors to better understand the link between cancer and thrombosis. The goal is to learn more, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help explain why cancer patients are more prone to dangerous blood clots, potentially pointing toward better prevention strategies.
What could go wrong: This is an observational study, not a treatment trial. It is small (120 participants) and early-stage, so findings may not apply broadly or lead directly to new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm Neoplastic Cells, Circulating thrombophilia due to thrombin defect thrombotic disease venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUMOR CELLS, CIRCULATING VENOUS THROMBOSIS

Contacts and locations

Locations

New Taipei City TuCheng Hospital
RECRUITING

New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.